In some cases PTX3 acts as tumor suppressor, inhibiting the proliferation and angiogenesis of FGF2-mediated tumor cells, as well as the epithelial-to-mesenchymal transition (EMT) and its metastatic potential. Here, FGF2 is linked to neoplasm.